Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Bone Micro-Architecture Using HR-pQCT
- Status
- COMPLETED
- Phase
- N/A
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
- Status
- COMPLETED
- Phase
- N/A
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3
- Status
- COMPLETED
- Phase
- PHASE4
Postoperative Residual Curarisation at Arrival in the Post-anesthesia Care Unit
- Status
- COMPLETED
- Phase
- N/A
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)
- Status
- COMPLETED
- Phase
- PHASE3
A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)
- Status
- TERMINATED
- Phase
- PHASE1
ROTATEQ™ Post-Marketing Surveillance in the Philippines
- Status
- TERMINATED
- Phase
- N/A
A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)
- Status
- COMPLETED
- Phase
- PHASE2
A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
- Status
- TERMINATED
- Phase
- N/A
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
- Status
- COMPLETED
- Phase
- N/A
GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)
- Status
- TERMINATED
- Phase
- N/A
A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)
- Status
- COMPLETED
- Phase
- N/A
Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2